Literature DB >> 11439374

Muscle glycogenoses.

S DiMauro1, C Lamperti.   

Abstract

There are 11 hereditary disorders of glycogen metabolism affecting muscle alone or together with other tissues, and they cause two main clinical syndromes: episodic, recurrent exercise intolerance with cramps, myalgia, and myoglobinuria; or fixed, often progressive weakness. Great strides have been made in our understanding of the molecular bases of these disorders, all of which show remarkable genetic heterogeneity. In contrast, the pathophysiological mechanisms underlying acute muscle breakdown and chronic weakness remain unclear. Although glycogen storage diseases have been studied for decades, new biochemical defects are still being discovered, especially in the glycolytic pathway. In addition, the pathogenesis of polyglucosan deposition is being clarified both in traditional glycogenoses and in disorders such as Lafora's disease. In some conditions, combined dietary and exercise regimens may be of help, and gene therapy, including recombinant enzyme replacement, is being actively pursued. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439374     DOI: 10.1002/mus.1103

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections.

Authors:  Gert Schaart; Reinout P Hesselink; Hans A Keizer; Gerrit van Kranenburg; Maarten R Drost; Matthijs K C Hesselink
Journal:  Histochem Cell Biol       Date:  2004-08-03       Impact factor: 4.304

Review 2.  A diagnostic algorithm for metabolic myopathies.

Authors:  Andres Berardo; Salvatore DiMauro; Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 3.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

4.  Glycogen metabolism in tissues from a mouse model of Lafora disease.

Authors:  Wei Wang; Hannes Lohi; Alexander V Skurat; Anna A DePaoli-Roach; Berge A Minassian; Peter J Roach
Journal:  Arch Biochem Biophys       Date:  2006-11-03       Impact factor: 4.013

5.  Novel method for detection of glycogen in cells.

Authors:  Alexander V Skurat; Dyann M Segvich; Anna A DePaoli-Roach; Peter J Roach
Journal:  Glycobiology       Date:  2017-05-01       Impact factor: 4.313

6.  Relationship between glycogen accumulation and the laforin dual specificity phosphatase.

Authors:  Wei Wang; Gretchen E Parker; Alexander V Skurat; Nina Raben; Anna A DePaoli-Roach; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2006-09-26       Impact factor: 3.575

7.  Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.

Authors:  Sixin Jiang; Brigitte Heller; Vincent S Tagliabracci; Lanmin Zhai; Jose M Irimia; Anna A DePaoli-Roach; Clark D Wells; Alexander V Skurat; Peter J Roach
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

8.  Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.

Authors:  Vincent S Tagliabracci; Jean Marie Girard; Dyann Segvich; Catalina Meyer; Julie Turnbull; Xiaochu Zhao; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

9.  Abnormal cardiac development in the absence of heart glycogen.

Authors:  Bartholomew A Pederson; Hanying Chen; Jill M Schroeder; Weinian Shou; Anna A DePaoli-Roach; Peter J Roach
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  [Metabolic and mitochondrial myopathies].

Authors:  M Vorgerd; M Deschauer
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.